Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct 1;12(7):569-73.
doi: 10.4161/cbt.12.7.17008. Epub 2011 Oct 1.

Clinical Significance of Myb Protein and Downstream Target Genes in Salivary Adenoid Cystic Carcinoma

Affiliations
Free PMC article

Clinical Significance of Myb Protein and Downstream Target Genes in Salivary Adenoid Cystic Carcinoma

Diana Bell et al. Cancer Biol Ther. .
Free PMC article

Abstract

Adenoid cystic carcinoma (ACC), the second most frequent malignancy of the major and minor salivary glands, comprise of approximately 15-23% of all carcinomas at these locations. ACC is uniquely formed of dual epithelial and myoepithelial cells that give rise to different phenotypic patterns. We hypothesize that the dual myoepithelial/ epithelial composition of ACCs underlie their biological heterogeneity and may impact on their therapeutic management. A recurrent reciprocal translocation of t(6;9)(q22-23; p23-24) resulting in fusion gene partners comprising MYB gene the transcription factor NFIB has been reported in ACC of breast, salivary, lachrymal and ceruminal glands. In fusion positive and a subset of fusion negative ACCs, high expression of the transcript Myb was found. However, the role of Myb protein expression and the potential effect on the downstream targets have not been investigated. To investigate the biological and prognostic significance of use of elevated levels of Myb and its downstream target genes (c-kit, cox-2, bcl-2), we analyzed, by immunohistochemistry, the protein expression of these genes in 156 ACCs. We have found that 55% of ACCs have increased Myb expression mainly confined to myoepithelial cells. We validated Myb expression on a large cohort of ACCs (156 patients). Although no significant effects of the individual Myb and downstream targets c-kit, bcl-2 and cox-2 on survival was noticed, the combinations survival curve for Myb+/c-kit+/cox-2+ showed better survival than combination Myb-/c-kit+/cox-2+. Myb may serve as a new target for the management of this disease, and future therapeutic trials of these tumors may be better based on biomarker stratification and the cellular composition of these tumors.

Figures

Figure 1
Figure 1
(A) The Kaplan-Meier plots of the overall survival of the population. (B–E) No significant correlation between individual markers (Myb, c-kit, cox-2, bcl-2) and survival was noticed. (F) Also, there was no significant correlation between different combinations of markers and survival, with the exception of Myb/c-kit/cox-2.

Similar articles

See all similar articles

Cited by 21 articles

See all "Cited by" articles

Publication types

MeSH terms

Substances

Feedback